MedPath

An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

Phase 1
Active, not recruiting
Conditions
Survivorship
Prostate Cancer
Interventions
Other: Waitlist Control
Procedure: Acupuncture
Other: Questionnaires
Registration Number
NCT05540392
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness (fatigue), sexual dysfunction, and cognitive (mental) difficulties.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • Age 18 or older
  • Prior PC diagnosis
  • No evidence of Prostate Cancer
  • Clinically meaningful nocturia, defined as ≥2 nocturia episodes every night for the past month
Exclusion Criteria
  • <1 month since completion of PC treatment (surgery, chemotherapy, radiation, ADT)
  • Score of ≥5 on the STOP-Bang questionnaire indicative of high risk of moderate-to severe obstructive sleep apnea
  • Other untreated primary sleep disorder (e.g. delayed/advanced sleep phase syndrome)
  • Untreated primary psychiatric disorder (e.g. bipolar disorder, schizophrenia, substance abuse, dementia)
  • Initiation of new medications for urinary symptoms in the past 4 weeks
  • Altered dosing of medications for urinary symptoms in the past 4 weeks
  • Plan to initiate/change medications or other treatments (e.g. surgery, behavioral intervention, complementary therapies) for urinary symptoms during the study
  • Implanted electronically charged medical device
  • Unable to provide consent for himself
  • Unwilling to adhere to all study-related procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Waitlist ControlWaitlist ControlThe waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.
AcupunctureAcupunctureAcupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.
Waitlist ControlQuestionnairesThe waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.
AcupunctureQuestionnairesAcupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.
Primary Outcome Measures
NameTimeMethod
success1 year

If a participant completes at least 8 out of 10 acupuncture sessions. Feasibility will be evaluated based on the respective definitions of success for the acupuncture.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Memorial Sloan Kettering Cancer Center Suffolk - Commack

🇺🇸

Commack, New York, United States

Memorial Sloan Kettering Bergen

🇺🇸

Montvale, New Jersey, United States

Memorial Sloan Kettering Monmouth

🇺🇸

Middletown, New Jersey, United States

Memorial Sloan Kettering Nassau

🇺🇸

Uniondale, New York, United States

Memorial Sloan Kettering Basking Ridge

🇺🇸

Basking Ridge, New Jersey, United States

MSK at Ralph Lauren (Consent Only)

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Westchester

🇺🇸

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath